Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS

Current Cardiovascular Risk Reports

ISSN 1932-9520 · eISSN 1932-9563 · Springer Nature · 12 issues per year

Current Cardiovascular Risk Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2 (journal website); hybrid open access; APC about USD 4,090; median 20 days to acceptance (11 articles, last 24 months); 23 articles in 2025; indexed in ESCI and Scopus.

Impact factor2From the journal's website, 2025 value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time20 daysMedian, submission to acceptance · 11 articles, last 24 months · Crossref
APCUSD 4,090Hybrid journal: charged only for open-access articles
Acceptance—No reports yet
Articles per year232025 · OpenAlex count

Scope

Aims, scope and focus

Current Cardiovascular Risk Reports is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Obesity, Physical Activity, Diet, Blood Pressure and Hypertension Studies and Lipoproteins and Cardiovascular Health, together about 21.6% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

The aim of this journal is to keep readers informed by providing cutting-edge reviews on key topics pertaining to cardiovascular risk. We use a systematic approach: international experts prepare timely articles on relevant topics that highlight the most important recent original publications. We accomplish this aim by appointing Section Editors in major subject areas across the discipline of cardiovascular medicine to select topics for review articles by leading experts who emphasize recent developments and highlight important papers published in the past year. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. We also provide commentaries from well-known figures in the field.

From the journal's Aims & Scope

Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS

Editor-in-chief Michael R. GoldPublisher website

Editorial board by country: 1 in mainland China (about 4%); most named United States 14, Mainland China 1, United Kingdom 1, France 1, Italy 1 (23 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Obesity, Physical Activity, DietMedicine7.9%
  2. Blood Pressure and Hypertension StudiesMedicine6.9%
  3. Lipoproteins and Cardiovascular HealthMedicine6.8%
  4. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine6.5%
  5. Cardiovascular Function and Risk FactorsMedicine4.7%
  6. Diet and metabolism studiesMedicine4.7%
  7. Cardiac Arrhythmias and TreatmentsMedicine4.5%
  8. Nutritional Studies and DietMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorCardiac & Cardiovascular SystemsZone 4

Top journal: noReview journal: yes

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorCardiac & Cardiovascular SystemsZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbasePublisher website

Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher) 2025
2Publisher website ·
5-year impact factor (publisher) 2025
2.5Publisher website ·
CiteScore 2026-06
3.7LetPub ·
SJR 2026-06
0.61LetPub ·
SNIP 2026-06
0.75LetPub ·
h-index
48OpenAlex ·
i10-index
205OpenAlex ·
2-year mean citedness
3.91OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
28.36%LetPub ·

Volume

Articles per year
23LetPub ·
Articles per year (publisher)
2,025Publisher website ·
Downloads per year (publisher) 2025
114,700Publisher website ·

Articles by year OpenAlex count · 934 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261050
2025239118
20242413105
2023219204
2022278245
2021207388

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

20 daysMedian, submission to acceptance · P25–P75 18 days – 84 days

Acceptance to online
median 18 days (31 articles)
Submission to online
median 50 days
Sample
11 articles with submission and acceptance dates (31 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Submission to first decision
3 daysPublisher website ·
Peer review
Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 4,090 / EUR 3,090 / GBP 2,690——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare4 items from the author guidelines
Abstract
150–250 words
Keywords
≥ 4
Reference style
Numbered, in order of citation
Suggested reviewers
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted2
  1. commentaryReviews and Invited Commentaries Back to topLength not stated
  2. reviewReviews and Invited Commentaries Back to topLength not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
AI use Generative AI Images

Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top

Source ↗Publisher website ·
Authorship Authorship principles

These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…

Source ↗Publisher website ·
Conflicts of interest Disclosures and declarations

All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …

Source ↗Publisher website ·
Data availability Data availability statements

All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…

Source ↗Publisher website ·
Publication ethics Compliance with Ethical Standards

To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…

Source ↗Publisher website ·
License & copyright Copyright

Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top

Source ↗Publisher website ·
Open access Open access publishing

To find out more about publishing your work Open Access in Current Cardiovascular Risk Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top

Source ↗Publisher website ·
Trial registration / reporting guidelines Clinical Trial Registration

The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Springer Nature
Frequency
12 issues per year
ISSN
1932-9520
Electronic ISSN
1932-9563
Official links

FAQ

Frequently asked questions about Current Cardiovascular Risk Reports

What CAS zone is Current Cardiovascular Risk Reports in?

In the 2025 upgraded edition of the CAS Journal Ranking, Current Cardiovascular Risk Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Current Cardiovascular Risk Reports?

The journal's website gives an impact factor of 2 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.7, h-index 48.

How long does peer review take at Current Cardiovascular Risk Reports?

Based on the dates recorded on 11 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 20 days (interquartile range 18–84 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Current Cardiovascular Risk Reports?

According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Current Cardiovascular Risk Reports based?

Of the 23 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are United States (14), Mainland China (1) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Current Cardiovascular Risk Reports?

According to LetPub and DOAJ records, Current Cardiovascular Risk Reports is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.

Is Current Cardiovascular Risk Reports open access, and what is the APC?

Current Cardiovascular Risk Reports is a hybrid journal. For open-access publication: APC about USD 4,090.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .